Agenda I status undoubtedly raises the volume of complexity for almost any investigate review. Such as, all scientists—no matter whether preclinical or medical—should acquire Timetable I study registrations. 21 CFR section 1301.18. By contrast, researchers who may have DEA Practitioner registrations in Schedules II–V (which most doctors would